Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion

Transplantation

Volumn 70, Issue 12, 2000, Pages 1761-1170

  Peralta, Carmen ^a   Bulbena, Oriol ^a   Bargalló, Robert ^b   Prats, Neus ^c   Gelpí, Emilio ^a   Roselló Catafau, Joan ^a,d  

^a INST D INVESTIGACIONS B   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 TERT BUTYL N [6 (2 HYDROXYETHOXY) 5 (3 METHOXYPHENOXY) 4 PYRIMIDINYL]BENZENESULFONAMIDE; AMINOTRANSFERASE; BOSENTAN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; GADOLINIUM CHLORIDE; LACTIC ACID; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; EDEMA; ENZYME ACTIVITY; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; LUNG INJURY; MALE; MICROANGIOPATHY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0034722920     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200012270-00016     Document Type: Article

References (57)

1. Preservation and reperfusion injuries in liver allografts: An overview and synthesis of current studies
2. Effect of end stage liver failure on the incidence and resolution of the adult respiratory distress syndrome
3. Experience with liver and kidney allografts from non-heart-beating donors
4. Prevention and treatment of ischemia of the liver
5. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
6. Endothelin-1 and in vitro evidence of renal artery, vasoconstriction after liver transplantation
7. Effect of the endothelin receptor antagonist bosentan on postischemic oxygen supply of the liver
8. Ischemia/reperfusion induces an increase in the hepatic portal vasoconstrictive response to endothelin-1
9. Endothelin up-regulation and localization following renal ischemia and reperfusion
10. Relative preservation of the responsiveness to endothelin-1 during reperfusion following renal ischemia in the rat
11. Endothelin-1 focally constricts pulmonary veins in rats
12. Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: Modulation by L-arginine
13. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat
14. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart-attenuation of ischemic injury by the endothelin-1 antagonists BQI23 and BQ610
15. Role of endogenous endothelin in extension of rabbit myocardial infarction
16. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation
17. Endothelin-1 induced increases in microvascular permeability in isolated, perfused
18. Endothelin receptor antagonist improves pulmonary hemodynamics during lung ischemia/reperfusion injury
19. Contribution of endothelin-1 to warm ischemia/reperfusion injury, of the rat lung
20. Endothelin-1 induced oedema in rat and guinea-pig isolated perfused lungs
21. Expression of endothelin-1 and effects of an endothelin receptor antagonist, TAK-044, at reperfusion after cold preservation in a canine lung transplantation model
22. Effect of the endothelin receptor antagonist bosentan on postischemic liver microcirculation
23. Effects of mixed ETA and ETB-receptor antagonist (Ro-47-0203) on hepatic microcirculation after warm ischemia
24. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances
25. Endothelin-1 stimulates the biosynthesis of tumor necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone
26. Different endothelins stimulate cytokine production by peritoneal macrophages and microglial cell line
27. Production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion
28. Role of tumor necrosis factor-α in the pathophysiologic alterations following hepatic ischemia/reperfusion in the rat
29. Role of tumor necrosis factor-α in disease states and inflammation
30. Effects of selective and non-selective endothelin antagonist on ischemia-reperfusion damage in the isolated perfused murine liver
31. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin
32. Cardiac preconditioning. Induction of endogenous tolerance to ischemia-reperfusion injury
33. Protection of the heart by ischaemic preconditioning: Mechanisms and possibilities for pharmacological exploitation
34. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion: Role of nitric oxide and adenosine
35. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats
36. The protective effect of ischemie and calcitonin gene-related peptide-induced preconditioning on myocardial injury by endothelin-1 in the isolated perfused rat heart
37. Ischemic preconditioning decreases postischemic myocardial tumor necrosis factor-alpha production: Potential ultimate effector mechanism of preconditioning
38. Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat
39. Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine
40. Endothelin mediated nitric oxide effects in ischemia-reperfusion associated with pancreas transplantation
41. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear
42. Endothelin 1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines
43. Nitric oxide enhances endothelin production in pancreas transplantation
44. Effects of endothelin-1 on vascular permeability in the conscious rat: Interactions with platelet-activating factor
45. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC
46. Hepatic ischemia/reperfusion injury: Importance oxidant/tumor necrosis factor interactions
47. Tumor necrosis factor-α mediates endotoxin-induced lung injury in platelet activating factor-primed rats
48. Myeloperoxidase in human lung lavage. I. A marker of local neotrophil activity
49. Myeloperoxidase as a biomarker of skin irritation and inflammation
50. Platelet-activating factor and nitric oxide mediate microvascular permeability in ischemia-reperfusion injury
51. The microvascular cell and ischemia-reperfusion injury
52. The "no-reflow" phenomenon after temporary coronary occlusion in dog
53. Effects of ischemia and hypercarbic acidosis on myocyte calcium transients, contraction, and pH in perfused rabbit hearts
54. Phosphoramidon blocks big-endothelin-1 but not endothelin-1 enhancement of vascular permeability in the rat
55. Treatment of primary liver graft nonfunction with prostaglandin E1
56. Total hepatectomy as a temporary approach to acute hepatic or primary graft failure
57. Increase in survival time of liver transplants by protease inhibitors and a calcium channel blocker, nisoldipine